NAOMI QUEZADA: Open Payments
NPI 1376150037 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 47 payments from 15 companies in 2025. Trend: 2023 $172 · 2024 $416 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $226 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $145 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Exact Sciences Corporation | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Novo Nordisk Inc | 4 | $62 |
| PFIZER INC. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Astellas Pharma US Inc | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $35 |
Products named: Kerendia, TRELEGY ELLIPTA, KISUNLA, JARDIANCE, MOUNJARO, XIFAXAN, Cologuard Collection Kit, Veozah.
Industry payments across NM — which companies pay providers there.
